Skip to main content

Unable to load price data. Sorry.

¯\_(ツ)_/¯

Genitope Corp (NASDAQOTCBB:GTOPQ)

CAPS Rating: No stars

A biotechnology company focused on the research and development of novel immunotherapies for the treatment of cancer.

Unable to load market data for this Ticker. Sorry.

¯\_(ツ)_/¯

Caps

This ticker is not currently Ratable.

Add Stock to CAPS Watchlist

All Players

43 Outperform
7 Underperform
 

All-Star Players

4 Outperform
3 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NASDAQOTCBB:GTOPQ Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

PotatoCapital (40.16)
Submitted December 20, 2007

We have a runner!

Top Bear Pitch

There are no pitches that meet the Top Bear criteria. Explain

If this upsets you, start recommending pitches below!

Fools bullish on NASDAQOTCBB:GTOPQ are also bullish on:

Fools bearish on NASDAQOTCBB:GTOPQ are also bearish on:

Recent Community Commentary

Read the most recent pitches from players about GTOPQ.

Recs

1
Member Avatar PotatoCapital (40.16) Submitted: 12/19/2007 11:01:03 PM : Outperform Start Price: $4.03 NASDAQ OTC:GTOPQ Score: -304.96

We have a runner!

Recs

0
Member Avatar barnesa13 (< 20) Submitted: 11/27/2007 4:20:03 PM : Outperform Start Price: $4.64 NASDAQ OTC:GTOPQ Score: -310.58

Approval of MyVax

Recs

1
Member Avatar jogger21 (< 20) Submitted: 11/21/2007 10:06:57 AM : Outperform Start Price: $4.49 NASDAQ OTC:GTOPQ Score: -313.12

The phase 3 trial results will be available by year end 2007. Past results have shown a cure rate for cancer in excess of 42%. If phase 3 results are the same as phase 2, the FDA will approve. Technonogy should also work on other forms of cancer. Look for buy out by major biotech company if results are good.

Leaderboard

Find the members with the highest scoring picks in GTOPQ.

Score Leader

hibetals

hibetals (91.70) Score: +311.34

The Score Leader is the player with the highest score across all their picks in GTOPQ.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
HAMRKF 80.87 12/20/2007 Underperform 5Y $2.46 -99.94% +206.44% +306.38 0 Comment
abetens1 < 20 5/11/2007 Underperform 5Y $3.39 -99.96% +201.79% +301.74 0 Comment
kkozma 97.85 11/30/2007 Underperform NS $4.11 -99.96% +201.72% +301.69 0 Comment
mikehav < 20 5/7/2007 Underperform 3M $3.83 -99.96% +199.54% +299.50 0 Comment
Geezeruk < 20 5/16/2007 Underperform 3W $3.69 -99.96% +198.79% +298.75 0 Comment
hibetals 91.70 5/17/2007 Underperform NS $3.54 -99.96% +198.23% +298.19 0 Comment
BetterMoney77 < 20 12/12/2007 Underperform NS $3.29 -99.95% +196.48% +296.44 0 Comment
jporter34 < 20 6/18/2007 Outperform 1Y $3.68 -99.96% +193.39% -293.35 0 Comment
Xcentric1 < 20 5/29/2007 Outperform 3M $3.75 -99.96% +197.60% -297.56 0 Comment
nguyenvanh < 20 7/2/2007 Outperform 1Y $3.89 -99.96% +198.26% -298.22 1 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for GTOPQ.